João L. Carapinha

Rifaximin Use Linked to Daptomycin Resistance: Implications for Antibiotic St...
NICE Rejects Donanemab for NHS Use Due to Cost Concerns
Innovative Pricing and Payment Models for Health Technologies
Draft European Medicines Agency Strategy 2028: Enhancing Accessibility and In...
Bupa Launches Whole Genome Sequencing Pilot in UK
KEYTRUDA Head Neck Cancer Phase 3 Trial